28/09/2011
Japan's Santen plans to buy Novagali for Eur 100 mln
Japanese drugmaker Santen Pharmaceutical said on Wednesday it has agreed to buy 50.55 percent of French eye care company Novagali from its main shareholders, followed by a tender offer for the rest of the company. Novagali shareholders IdInvest Partners have agreed to sell their shares at a 71.3 percent premium...
Read more on Reuters.com
